THE WOODLANDS, Texas, Sept. 24 /PRNewswire/ -- US Oncology, Inc., the nation's foremost cancer treatment and research network, announced today that Yon Yoon Jorden, former chief financial officer of four publicly traded companies, and Todd Vannucci, managing director with Morgan Stanley & Co., have joined the board of directors of US Oncology, Inc., and its parent company, US Oncology Holdings, Inc. Jorden has also been selected to serve as an audit committee member on each board.
"Yon has been a key player in several health care payer organizations, and I look forward to her input and guidance as we continue to develop our payer-facing businesses and enhance our informatics capabilities," Broussard said. "Todd's financial knowledge and experience in private equity and capital markets will be a great asset to the board and management, and we are pleased to have the continued support and guidance of a representative from Morgan Stanley, our second largest stockholder."
Vannucci, 48, is managing director of Morgan Stanley & Co. in its Morgan Stanley Principal Investments division. Mr. Vannucci has been with Morgan Stanley since 1998. Until this year he was in Morgan Stanley's Global Capital Markets division.
US Oncology uses its expertise to support every aspect of the cancer care delivery system--from drug development to distribution and outcomes measurement--enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,227 physicians operating in 468 locations, including 95 radiation oncology facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.
US Oncology, Inc.
